Network members

You are here

PETAL Network press release on CLOVERS Trial

nringwood's picture

As physicians and scientists, our goal is to advance the care and treatment of sepsis, which claims the lives of more than 250,000 Americans every year. This study compares two approaches for the treatment of septic shock that are both currently in widespread use. Our study will provide clinicians with authoritative data on which approach leads to better patient outcomes. The study protocol was designed by expert clinicians in emergency and critical care medicine representing nearly 50 hospitals in the United States and follows a well-accepted design. To ensure that the study meets the highest scientific and ethical standards, the study was thoroughly reviewed by an independent protocol review committee and a Data Safety and Monitoring Board appointed by the National Heart, Lung, and Blood Institute (the study’s funder), and a central Institutional Review Board, before the study began.

Inquiries related to the CLOVERS trial should be directed to the Beth Israel Deaconess Medical Center media relations office at the following address:

Jacqueline Mitchell | Senior Science Communications Manager
Beth Israel Deaconess Medical Center
109 Brookline Avenue
Boston, MA 02215
P. 617-667-7306| F. 617-667-7317|E.